Statistics
Publications
3
Citations
52
H-Index
3
Active since
2022
Affiliations
Astellas Pharma (Japan)(Current)
Yoshihiro Nishizono is an author at Astellas Pharma (Japan) specializing in tumor biology, cancer research, and pharmacology.
Publications per year
2022–2025
3
3
Discovery of KRAS(G12D) selective degrader ASP3082
Tomohiro Yoshinari, Takeyuki Nagashima, Hiroki Ishioka et al. · Communications Chemistry · 2025 · 18 citations · Full text
Mucin 21 confers resistance to apoptosis in an O-glycosylation-dependent manner
Yuan Tian, Kaori Denda‐Nagai, Tatsuya Tsukui et al. · Cell Death Discovery · 2022 · 17 citations · Full text
Apoptosis, Glycobiology, Immunology +21
Takeyuki Nagashima, Tomohiro Yoshinari, Yoshihiro Nishizono et al. · Cancer Research · 2023 · 17 citations
Dose-dependent Kras Degradation, Asp3082 Monotherapy, Abstract 5735 +17
Rows per page
1–3 of 3